PD-1 monoclonal antibody
Drug timelines are a Plus or Pro feature.
34 regulatory and trial events tracked for PD-1 monoclonal antibody, covering 2019-09-20 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: PD-1 Monoclonal Antibody Combined With Gemcitabine and Cisplatin Followed by Selective Radiotherapy for Unresectable Locally Recurrent NPC [Phase 2]